Synthetic T and B cell recognition sites: implications for vaccine development.
about
TLR Agonist Augments Prophylactic Potential of Acid Inducible Antigen Rv3203 against Mycobacterium tuberculosis H37Rv in Experimental AnimalsEnhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopesSVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity.Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell responseProtection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire.Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic miceInduction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clonesMapping of B-cell epitopes of the human hepatitis B virus X protein.H-2Kd-restricted antigenic peptides share a simple binding motif.Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution.
P2860
Q27316456-68F19EBC-9C59-499B-ACC8-37E2CF5B7661Q27486235-7FD0441A-3DEA-43F9-8C7D-4B252175D2BAQ34416400-5BAF3D21-E97D-4F2D-B139-8E52FC8B2190Q35814043-D77E7854-9110-42DF-96E4-6EBD5633C940Q35833713-31A00288-0A68-4347-84DD-5F0731AAFEA3Q36230696-4CEFE28A-456C-44B5-A68B-47CC2F408C21Q36277371-3F897D6D-0E94-41F7-A4CE-8A66C006DDEEQ36363704-FC72A7E6-26E3-418F-9B5A-CB8D85F750E4Q36635959-1F66D1C3-20CD-4CC2-AB18-27E37DA80B17Q36685422-D1E81E29-2FCE-48FB-91B9-B425759497D3Q40109237-86A82062-7634-49EA-BADF-80AF66D67D0AQ42768137-652EBF3B-672B-4687-B394-042C9DD99A6AQ42768349-D0E753EB-A044-4D80-9C48-4F1BA397783B
P2860
Synthetic T and B cell recognition sites: implications for vaccine development.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Synthetic T and B cell recognition sites: implications for vaccine development.
@en
type
label
Synthetic T and B cell recognition sites: implications for vaccine development.
@en
prefLabel
Synthetic T and B cell recognition sites: implications for vaccine development.
@en
P1476
Synthetic T and B cell recognition sites: implications for vaccine development.
@en
P2093
P304
P577
1989-01-01T00:00:00Z